^○Kentaro Yamazaki¹, Takafumi Koyama², Toshio Shimizu², Akiko Todaka¹, Takeshi Kawakami¹, Jangsoo Yoon³, Damijan Erzen⁴, Jianrui Hou³, Noboru Yamamoto² (1.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 2.Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan, 3.Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan, 4.Boehringer Ingelheim GmbH, Ingelheim, Germany)

^○Kentaro Yamazaki¹, Takayuki Yoshino², Kazunori Honda³, Yasutoshi Kuboki², Takeshi Kawakami¹, Seiichiro Mitani³, Yoshiaki Nakamura², Hiroya Taniguchi³, Hideaki Bando², Tomoyuki Tanaka⁴, Keisuke Tada⁴, Nathalie Fagniez⁵, Kei Muro³ (1.Shizuoka Cancer Center, Shizuoka, Japan, 2.National Cancer Center Hospital East, Chiba, Japan, 3.Aichi Cancer Center Hospital, Aichi, Japan, 4.Sanofi, Tokyo, Japan, 5.Sanofi, Chilly-Mazarin, France)

^○Izuma Nakayama¹, Eiji Shinozaki¹, Mayu Yunokawa², Maki Matoda³, Takashi Sasaki⁴, Takeshi Yuasa⁵, Jyunichi Tomomatsu², Satoru Kitazono⁶, Kokoro Kobayashi⁷, Keiko Hayakawa⁸, Risa Ueki⁹, Shunji Takahashi², Kensei Yamaguchi¹ (1.Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the JFCR, 2.Department of Medical Oncology, Cancer Institute Hospital of the JFCR, 3.Department of Gynecologic Oncology, Cancer Institute Hospital of the JFCR, 4.Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of the JFCR, 5.Division of Genitourinary Chemotherapy, Cancer Institute Hospital of the JFCR, 6.Department of Thoracic Medical Oncology, Cancer Institute Hospital of the JFCR, 7.Department of Breast Medical Oncology, Cancer Institute Hospital of the JFCR, 8.Department of Orthopedic Oncology, Cancer Institute Hospital of the JFCR, 9.Department of Clinical Genetic Oncology, Cancer Institute Hospital of the JFCR)

^○Nobuaki Mamesaya^1,2, Masakuni Serizawa³, Eriko Miyawaki^1,2, Ryo Koh^1,2, Kunihiro Fushiki^2,4, Hiromitsu Shirasu^2,4, Nobuhiro Kado^2,5, Rina Umehara³, Kana Kunitomo², Nao Kawamura², Naomi Fukuzaki², Satomi Higashigawa², Yoshimi Kiyozumi², Hiroyuki Matsubayashi², Hirofumi Yasui^2,4, Hirotsugu Kenmotsu^1,2 (1.Division of Thoracic Oncology, Shizuoka Cancer Center, 2.Division of Genetic Medicine Promotion, Shizuoka Cancer Center, 3.Division of Drug Discovery & Development, Shizuoka Cancer Center, 4.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 5.Division of Gynecology, Shizuoka Cancer Center)

^○Shiro Kimbara¹, Meiko Nishimura¹, Masanori Toyoda¹, Yasuko Hyogo¹, Naomi Kiyota¹, Masato Komatsu², Hiroaki Hanafusa³, Yui Niwa⁴, Keiko Tanaka⁴, Megumi Uchida⁵, Yui Wada⁵, Takuto Hara⁶, Nobuyuki Yamamoto³, Kazutoshi Tobimatsu⁷, Eiji Nakano⁸, Motoko Tachihara⁹, Takashi Sasayama¹⁰, Minami Hironobu¹ (1.Department of Medical Oncology/Hematology, Kobe University Hospital, 2.Department of Diagnostic Pathology, Kobe University Hospital, 3.Department of Pediatrics, Kobe University Hospital, 4.Department of Clinical Genetics, Kobe University Hospital, 5.Division of Nursing, Kobe University Hospital, 6.Department of Urology, Kobe University Hospital, 7.Department of Gastroenterology, Kobe University Hospital, 8.Department of Dermatology, Kobe University Hospital, 9.Department of Respiratory Medicine, Kobe University Hospital, 10.Department of Neurosurgery, Kobe University Hospital)

^○Tatsuki Ikoma^1,5, Hiroshi Tato², Takanobu Shimada¹, Keitaro Doi¹, Takahito Ashihara³, Takahumi Nonogaki³, Hiroyuki Marusawa⁴, Toshihide Shimada², Takehiko Tsumura^1,4 (1.Department of Medical Oncology, Osaka Red Cross Hospital, 2.Department of Pathology, Osaka Red Cross Hospital, 3.Department of Gynecology, Osaka Red Cross Hospital, 4.Department of Gastroenterology, Osaka Red Cross Hospital, 5.Department of Medical Oncology, Kobe City Medical Center General Hospital)